Jpmorgan Chase & Co »

Lineage Cell Therapeutics In shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $613k 677k 0.91
2024-06-30 $593k 594k 1.00
2024-03-31 $1.0M 676k 1.48
2023-12-31 $792k 727k 1.09
2023-09-30 $837k 710k 1.18
2023-06-30 $1.5M 1.0M 1.41
2023-03-31 $0 1.1M 0.00
2022-12-31 $1.3M 1.1M 1.17
2022-06-30 $2.0M 1.3M 1.58
2022-03-31 $2.8M 1.8M 1.51
2021-12-31 $3.1M 1.3M 2.45
2021-03-31 $0 73 0.00
2020-12-31 $4.1k 2.3k 1.83
2020-09-30 $12k 13k 0.96
2020-06-30 $5.1k 5.5k 0.92
2020-03-31 $148k 179k 0.83
2019-12-31 $126k 142k 0.89
2019-09-30 $35k 36k 0.99